File photo of abortion pill. Photo/File/CBS News

As Joe Biden seeks to lift restrictions on life-ending abortion pills, dubbed “death by mail” by some groups, pro-life state legislatures are moving to ban or heavily restrict the pills. The Centers for Disease Control and Prevention reported that telemedicine spiked in the last week of March 2020 compared with the same period of time in 2019, going up by an increase of 154%, reports Daily Wire.

The report reads:

Montana and Ohio recently saw efforts by the GOP-led legislature to place restrictions on the ability for people to obtain abortion pills through the use of telemedicine.

HB171 is a bill that was recently passed in Montana and is set to be signed by Republican Governor Greg Gianforte. It addresses the issue of chemical abortion and telemedicine. The language of the bill states that its purpose is “ensuring that a medical practitioner examines a woman prior to dispensing an abortion-inducing drug in order to confirm the gestational age of the unborn child, the intrauterine location of the unborn child, and that the unborn child is alive because the routine administration of an abortion-inducing drug following spontaneous miscarriage is unnecessary and exposes the woman to unnecessary risks associated with the abortion-inducing drug.”

Ohio also sought a ban on the use of telemedicine for chemical abortions. It was scheduled to take effect last week but was halted by a judge who granted a restraining order in a case brought by Planned Parenthood against the Ohio Department of Health, Ohio’s Medical Board and prosecutors from some counties, The Associated Press reported.

Abortion pills were first approved by the U.S. Food and Drug Administration in 2000 with an approved regimen included in 2016.

Joe Biden’s Federal Drug Administration announced on Tuesday that the Administration proclaimed the at-home abortions were safe and would expand the use of the drug, which was limited by the Donald Trump administration.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments